Please login to the form below

Blue Latitude Health joins Fishawack Group of Companies

Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.

Blue Latitude Health is delighted to announce that we have joined the Fishawack Group of Companies as part of our international growth plans.

The partnership comes after an outstanding year in which we welcomed new clients, moved to new offices in Barbican, Central London, and have expanded our New York team.

“Since we set up the company in 2003 our growth has been strong and organic. In the last year alone, we have seen double digit growth in both the UK and US”, said Martin Brass, MD and Co-founder of Blue Latitude Health.

“To enable us to continue to grow and provide existing and future clients with a stronger offering, we needed to find a partner who shared both our values and matched our ambition. We believe we have found this partner in Fishawack.’’

Fred Bassett, Head of Strategy and Co-founder of Blue Latitude Health, added, “We are thrilled to join an organisation with the global scale and extended services in medical and scientific communications that Fishawack offers. Our strategic and commercial focus will complement Fishawack’s scientific and medical foundations and allow us to expand our reach, particularly in the US, while deepening our client relationships.”

Fishawack is one of the world’s leading independent medical communications and medical marketing agencies, with offices in London, Oxford, Knutsford, Brighton, San Diego, Philadelphia, and India. The organisation has more than 400 members of staff, including more than 120 medical experts and writers, 90% of whom have PhDs, PharmDs or MDs. The depth and breadth of its scientific and medical expertise, coupled with its unique physician-partnered consulting model, truly delivers our clients an enhanced offering at all stages of the product lifecycle.

“Just like Blue Latitude Health, Fishawack work with some of the biggest global pharmaceutical, biotech and healthcare innovators,’’ added Simon Young, Commerical Director.

Although we have some clients in common with Fishawack, we also have clients that are unique to each company and therefore there is great potential to offer both existing and new clients an extended and unbeatable service. This new partnership compliments Fishawack’s vision to expand its commercial capabilities by incorporating our strong foundation of strategic and user experience skills into the wider group.

“Blue Latitude Health have an excellent reputation in the industry and are known for the quality of their work’’, explained Oliver Dennis, Chief Executive Officer at Fishawack Group of Companies. “We were actively looking for a consultancy who could bring strategic and customer experience expertise to our portfolio. We are delighted to be able to bring these capabilities to our existing and future clients.”

The medical organisation is also focused on growing its creative capability and is keen to harness our end-to-end creative skills, as one of the world’s first creative marketing consultancies, to its repertoire.

Chris Field, Head of Creative Services at Blue Latitude Health, explained: “Our clients will benefit by having access to a larger and more diverse creative team. So long as it provides our clients commercial impact, we are un-restricted in our ability to execute – from conceptual through to digital, motion graphics, and event logistics, all supported by an expanded range of therapy area experiences.”

We’re excited for this new chapter and the opportunities it brings. For more information about Blue Latitude Health and our recent partnership, please contact martin.brass@bluelatitude.com

12th December 2018

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

The changing face of pharma in the precision era
Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.
Blue Latitude Health
Creative problem solving, solved
Customer Experience Consultant Eimear Power explains how pharma teams can unlock their creativity and foster truly innovative ideas.
Blue Latitude Health
Three strategies for managing loss of exclusivity successfully
Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
Blue Latitude Health
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
Blue Latitude Health
Diagnosing the lag in neuropsychiatric treatments
The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.
Blue Latitude Health